Cell Growth & Differentiation, Vol 8, Issue 7 801-809, Copyright © 1997 by American Association of Cancer Research

ARTICLES

Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage

JE Thomas, M Smith, JL Tonkinson, B Rubinfeld and P Polakis
Department of Cancer Research, Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana 46285, USA. Thomas_James_E@lilly.com

BRCA1, the familial breast cancer susceptibility gene product, is a 220-kDA phosphorylated protein. BRCA1 immunoprecipitated from MCF7 cells blocked in G1-S phase or progressing through S-phase of the cell cycle migrated more slowly through SDS polyacrylamide gels than BRCA1 from cells maintained in serum-supplemented media, serum-free media for 24 h, or delayed in G2-M phase by treatment with colchicine. Restoration of BRCA1 to the faster-migrating form, which occurred on release of cells from the G1-S-phase block, was prevented by the phosphatase inhibitor okadaic acid. Phosphatase treatment of immunoprecipitated BRCA1 resulted in the conversion of the slower-migrating form to the faster-migrating form. Although these results suggested that BRCA1 was preferentially hyperphosphorylated near the G1-S-phase boundary of the cell cycle, exposure of cells to DNA-damaging agents including UV light or treatment with hydrogen peroxide (H2O2) also promoted BRCA1 hyperphosphorylation. These same stimuli also eliminated the punctate nuclear staining pattern normally observed for BRCA1 in control cells. These results indicate that BRCA1 undergoes cyclic hyperphosphorylation during the cell cycle; however, this modification, as well as changes in BRCA1 nuclear staining, also occurs in response to DNA damage.

This article has been cited by other articles:

				M. C. Korrapati, J. Chilakapati, E. A. Lock, J. R. Latendresse, A. Warbritton, and H. M. Mehendale Preplaced cell division: a critical mechanism of autoprotection against S-1,2-dichlorovinyl-L-cysteine-induced acute renal failure and death in mice Am J Physiol Renal Physiol, August 1, 2006; 291(2): F439 - F455. [Abstract] [Full Text] [PDF]

				E M Rosen, S Fan, and C Isaacs BRCA1 in hormonal carcinogenesis: basic and clinical research Endocr. Relat. Cancer, September 1, 2005; 12(3): 533 - 548. [Abstract] [Full Text] [PDF]

				A. D. Choudhury, H. Xu, A. P. Modi, W. Zhang, T. Ludwig, and R. Baer Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells J. Biol. Chem., July 1, 2005; 280(26): 24669 - 24679. [Abstract] [Full Text] [PDF]

				A. D. Choudhury, H. Xu, and R. Baer Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression J. Biol. Chem., August 6, 2004; 279(32): 33909 - 33918. [Abstract] [Full Text] [PDF]

				T. Miralem and H. K. Avraham Extracellular Matrix Enhances Heregulin-Dependent BRCA1 Phosphorylation and Suppresses BRCA1 Expression through Its C Terminus Mol. Cell. Biol., January 15, 2003; 23(2): 579 - 593. [Abstract] [Full Text] [PDF]

				Y. Liu, D. M. Virshup, R. L. White, and L.-C. Hsu Regulation of BRCA1 Phosphorylation by Interaction with Protein Phosphatase 1{alpha} Cancer Res., November 15, 2002; 62(22): 6357 - 6361. [Abstract] [Full Text] [PDF]

				L. J. Huber, T. W. Yang, C. J. Sarkisian, S. R. Master, C.-X. Deng, and L. A. Chodosh Impaired DNA Damage Response in Cells Expressing an Exon 11-Deleted Murine Brca1 Variant That Localizes to Nuclear Foci Mol. Cell. Biol., June 15, 2001; 21(12): 4005 - 4015. [Abstract] [Full Text]

				H. Ruffner, C. A. P. Joazeiro, D. Hemmati, T. Hunter, and I. M. Verma Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity PNAS, April 24, 2001; 98(9): 5134 - 5139. [Abstract] [Full Text] [PDF]

				J. Vallon-Christersson, C. Cayanan, K. Haraldsson, N. Loman, J. T. Bergthorsson, K. Brondum-Nielsen, A.-M. Gerdes, P. Moller, U. Kristoffersson, H. Olsson, et al. Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families Hum. Mol. Genet., February 1, 2001; 10(4): 353 - 360. [Abstract] [Full Text] [PDF]

				P. Arizti, L. Fang, I. Park, Y. Yin, E. Solomon, T. Ouchi, S. A. Aaronson, and S. W. Lee Tumor Suppressor p53 Is Required To Modulate BRCA1 Expression Mol. Cell. Biol., October 15, 2000; 20(20): 7450 - 7459. [Abstract] [Full Text]

				J. Chen Ataxia Telangiectasia-related Protein Is Involved in the Phosphorylation of BRCA1 following Deoxyribonucleic Acid Damage Cancer Res., September 1, 2000; 60(18): 5037 - 5039. [Abstract] [Full Text]

				J. A. Thompson, P-L. Chen, R. A. King, S. S. Rich, W. S. Oetting, C. Armstrong, A. R. Folsom, and T. A. Sellers BRCA1 Susceptibility Markers and Postmenopausal Breast Cancer: The Iowa Women's Health Study Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 507 - 511. [Abstract] [Full Text]

				F. Hayes, C. Cayanan, D. Barillà, and A. N. A. Monteiro Functional Assay for BRCA1: Mutagenesis of the COOH-Terminal Region Reveals Critical Residues for Transcription Activation Cancer Res., May 1, 2000; 60(9): 2411 - 2418. [Abstract] [Full Text]

				G. M. Pao, R. Janknecht, H. Ruffner, T. Hunter, and I. M. Verma CBP/p300 interact with and function as transcriptional coactivators of BRCA1 PNAS, February 1, 2000; 97(3): 1020 - 1025. [Abstract] [Full Text] [PDF]

				S. Altiok, D. Batt, N. Altiok, A. Papautsky, J. Downward, T. M. Roberts, and H. Avraham Heregulin Induces Phosphorylation of BRCA1 through Phosphatidylinositol 3-Kinase/AKT in Breast Cancer Cells J. Biol. Chem., November 5, 1999; 274(45): 32274 - 32278. [Abstract] [Full Text] [PDF]

				T.-C. Suen and P. E. Goss Transcription of BRCA1 Is Dependent on the Formation of a Specific Protein-DNA Complex on the Minimal BRCA1 Bi-directional Promoter J. Biol. Chem., October 29, 1999; 274(44): 31297 - 31304. [Abstract] [Full Text] [PDF]

				H. Ruffner, W. Jiang, A. G. Craig, T. Hunter, and I. M. Verma BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site Mol. Cell. Biol., July 1, 1999; 19(7): 4843 - 4854. [Abstract] [Full Text] [PDF]

				S. Thakur and C. M. Croce Positive Regulation of the BRCA1 Promoter J. Biol. Chem., March 26, 1999; 274(13): 8837 - 8843. [Abstract] [Full Text] [PDF]

				L.-C. Hsu and R. L. White BRCA1 is associated with the centrosome during mitosis PNAS, October 27, 1998; 95(22): 12983 - 12988. [Abstract] [Full Text] [PDF]

				X. Yu, L. C. Wu, A. M. Bowcock, A. Aronheim, and R. Baer The C-terminal (BRCT) Domains of BRCA1 Interact in Vivo with CtIP, a Protein Implicated in the CtBP Pathway of Transcriptional Repression J. Biol. Chem., September 25, 1998; 273(39): 25388 - 25392. [Abstract] [Full Text] [PDF]

				L. C. Gowen, A. V. Avrutskaya, A. M. Latour, B. H. Koller, and S. A. Leadon BRCA1 Required for Transcription-Coupled Repair of Oxidative DNA Damage Science, August 14, 1998; 281(5379): 1009 - 1012. [Abstract] [Full Text]

				X. Yu and R. Baer Nuclear Localization and Cell Cycle-specific Expression of CtIP, a Protein That Associates with the BRCA1 Tumor Suppressor J. Biol. Chem., June 9, 2000; 275(24): 18541 - 18549. [Abstract] [Full Text] [PDF]